CinnaGen Enters EU Market with EMA Approval for Zandoriah®
Corporate Governance
Revealing the human and business cost of clinical trial inefficiencies for Data Managers and CRAs
Mastering compliance and copyright in healthcare and MedComms
Driving bioscience innovation: How Teesside University empowers industry breakthroughs
JP Morgan 2025: Jazz Pharmaceuticals focusing on oncology pipeline
Study finds restrictive clinical trial criteria excludes Lyme disease patients
Percheron plans to broaden pipeline following avicursen disappointment
Zepbound will dominate obesity market following SURMOUNT-5 results, says analyst
